×
About 25,725 results

Low-Protein Nordic Diet Promotes Healthy Eating in Infants
https://www.medscape.com/viewarticle/976272

Jun 27th, 2022 - Infants who were introduced to a low-protein diet – high in fruit, vegetables, and roots – ate more fruits and vegetables at 12 and 18 months of age, compared with those who ate a conventional diet, in a new study. The "Nordic diet" has shown health benefits in children and adults, but has not been studied in infants, said Ulrica Johansson, MD, of Umeå (Sweden) University, in a presentation on ...

Acute Hepatitis Cases in Children Show Declining Trend; Adenovirus, COVID-19 Remain Key Leads
https://www.medscape.com/viewarticle/976174

Jun 24th, 2022 - LONDON ― Case numbers of acute hepatitis in children show "a declining trajectory," and COVID-19 and adenovirus remain the most likely, but as yet unproven, causative agents, said experts in an update at the International Liver Congress (ILC) 2022. Philippa Easterbrook, MD, medical expert at the World Health Organization (WHO) Global HIV, Hepatitis, and STI Programme, shared the latest case num...

EU Seeks to Halve Use of Pesticides, Heal Nature With Landmark Laws
https://www.medscape.com/viewarticle/976018

Jun 23rd, 2022 - BRUSSELS (Reuters) - The European Commission proposed on Wednesday legally binding targets to halve the use of chemical pesticides and restore nature across the EU, in an attempt to better protect health and recover plunging wildlife populations. European Union environment policy chief Virginijus Sinkevicius told Reuters the proposal on repairing habitats would require EU countries to take step...

US Woman Fearing for Health After Malta Refuses Abortion
https://www.medscape.com/viewarticle/976026

Jun 23rd, 2022 - VALLETTA (Reuters) - An American couple on Wednesday appealed to the Maltese authorities to let them leave Malta to have an abortion and avoid any risks to the mother after she suffered symptoms of a miscarriage. Malta is the only country in the European Union which does not allow abortion under any circumstances. Andrea Prudente and her partner Jay Weeldreyer, from Seattle, were on holiday on ...

EU to Boost Investment in Latin American Vaccine, Drug Production
https://www.medscape.com/viewarticle/976048

Jun 23rd, 2022 - BRUSSELS (Reuters) - The European Union wants to boost production of vaccines and drugs in Latin America by investing more in the region and by sharing technologies and regulatory practices, the head of the European Commission said on Wednesday. Under attack in developing countries for blocking a global temporary waiver on COVID-19 vaccine patents, the EU has launched several initiatives to boo...

Antibiotics During Pregnancy May Increase Child's Risk for Asthma and Other Atopic Diseases
https://www.medscape.com/viewarticle/976097

Jun 23rd, 2022 - Children born to mothers who take antibiotics during pregnancy may be at an increased risk of developing pediatric asthma and other diseases involved in the atopic march, a systematic review and meta-analysis reports. "Antibiotic use during pregnancy is significantly associated with the development of asthma in children. Additionally prenatal antibiotic exposure is also associated with disorder...

Tofersen Linked to Slow but Positive ALS Outcomes
https://www.medscape.com/viewarticle/976134

Jun 23rd, 2022 - An open-label extension of Biogen's phase 3 VALOR study shows statistically significant benefits for the company's novel antisense oligonucleotide (ASO), tofersen, in patients with amyotrophic lateral sclerosis (ALS) caused by superoxide dismutase 1 (SOD1) gene mutations. The 1-year results, presented at the European Network for the Cure of Amyotrophic Lateral Sclerosis (ENCALS) 2022 meeting, s...

Introduce Allergens Early, Say French Allergologists
https://www.medscape.com/viewarticle/976029

Jun 22nd, 2022 - LILLE, France ― Although in many cases, food-allergen tolerance can be achieved with oral immunotherapy, primary prevention of food allergies remains crucial, according to the French Society of Allergology. In new recommendations that were presented at a session of the Congress of French Pediatric Societies, the academic society advocated early introduction of allergens for all children, starti...

When Giving IV Fluids in Septic Shock Cases, Less Is Not More
https://www.medscape.com/viewarticle/975793

Jun 21st, 2022 - (Reuters Health) - Restricting intravenous fluids in ICU patients with septic shock does not lower the 90-day death rate, a large European study of 1,554 adults concludes. Little hard information exists on the best volume of IV fluid to use in patients with septic shock, a leading cause of death. There's evidence that higher volumes are harmful because they might injure the kidney, produce resp...

Osteoporosis Risk Rises With Air Pollution Levels 
https://www.medscape.com/viewarticle/975959

Jun 21st, 2022 - COPENHAGEN — Chronic exposure to high levels of particulate matter (PM) air pollution 2.5 micrometers (PM2.5) or larger, and 10 micrometers (PM10) or larger, in size is associated with a significantly higher likelihood of having osteoporosis, according to research presented at the European Alliance of Associations for Rheumatology (EULAR) 2022 Annual Meeting. Dr Giovanni Adami The results of th...

FDA Okays Cancer Drugs Faster Than EMA. But at What Cost?
https://www.medscape.com/viewarticle/975887

Jun 20th, 2022 - Over the past decade, the US Food and Drug Administration (FDA) has approved new cancer drugs twice as fast as the European Medicines Agency (EMA), often using accelerated pathways, a new analysis shows. Between 2010 and 2019, the FDA approved almost all oncology therapies ahead of the EMA. Drugs entered the US market about 8 months (241 days) before European market authorization. But do quicke...

EU Drugs Watchdog Begins Review of Moderna's Variant COVID Vaccine
https://www.medscape.com/viewarticle/975822

Jun 20th, 2022 - LONDON (Reuters) - The European Medicines Agency (EMA) started a rolling review on Friday of a variant-adapted COVID-19 vaccine from Moderna, as coronavirus cases linked to Omicron sublineages see an uptick in the region. U.S.-based Moderna's bivalent vaccine targets two strains of the SARS-CoV-2 virus behind COVID, an early version of the original strain first identified in China, and the Omic...

Italy Sees First Assisted Suicide After Years of Court Battles
https://www.medscape.com/viewarticle/975717

Jun 17th, 2022 - ROME (Reuters) - An Italian man, paralysed 12 years ago in a traffic accident, died on Thursday in Italy's first case of assisted suicide, according to an association that has long campaigned for legal euthanasia. Federico Carboni, 44, died with his family at his bedside after administrating the lethal medicines himself via a specially designed machine. "I don't deny that I regret saying goodby...

MRI Plus Deep Learning Models Estimate Brain-Aging
https://www.medscape.com/viewarticle/975802

Jun 17th, 2022 - The study covered in this summary was published in bioRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Using the Layer-wise Relevance Propagation algorithm and various structural MRI modalities (T1-weighted, fluid-attenuated inversion recovery [FLAIR], and susceptibility-weighted magnitude images [SWI]), brain age can be estimated. The structural abnormalities found were...

Zanubrutinib-Obinutuzumab Doubles PFS in Follicular Lymphoma
https://www.medscape.com/viewarticle/975836

Jun 17th, 2022 - UPDATED June 21, 2022 // Editor's note: This article has been updated with comments. For patients with follicular lymphoma, adding zanubrutinib to obinutuzumab more than doubled progression-free survival (PFS) compared with use of obinutuzumab alone, new phase 2 research shows. Overall, the combination therapy was associated with a 49% lower risk of progression or death compared with obinutuzum...

New CAR-T Therapy Elicits Strong Response in Multiple Myeloma
https://www.medscape.com/viewarticle/975749

Jun 16th, 2022 - All 30 patients with relapsed/refractory multiple myeloma who received a new CAR T-cell therapy, ARI0002h, responded to the investigational agent, with almost two thirds achieving complete remission at 16 months, new data show. Most patients did not experience limiting toxicities after a single dose, and some showed additional improvements following a second infusion. Dr Carlos Fernandez De Lar...

EU States Step Up Pressure on Pfizer to Cut Unneeded COVID Vaccine Supplies
https://www.medscape.com/viewarticle/975548

Jun 15th, 2022 - BRUSSELS (Reuters) - European Union governments are intensifying pressure on Pfizer and other COVID-19 vaccine makers to renegotiate contracts, warning millions of shots that are no longer needed could go to waste, according to EU officials and a document. During the most acute phase of the pandemic, the European Commission and EU governments agreed to buy huge volumes of vaccines, mostly from ...

Multispecialty Team Diagnoses and Removes Glomus Tumor
https://www.medscape.com/viewarticle/975665

Jun 15th, 2022 - After 30 minutes of surgery, a woman in Armenia can knit without pain for the first time in over 40 years, thanks to teamwork by a group of specialists who removed a rare glomus tumor from under her fingernail, according to a new case study. Dr Mikhail Dziadzko "The cause of a patient's pain isn't always obvious. In a puzzling case such as this one involving a glomus tumor, which is rare, a mul...

Ancient Human Teeth Revise the History of Microbial Evolution
https://www.medscape.com/viewarticle/975668

Jun 15th, 2022 - The cupboard in Nicolás Rascovan's microbial paleogenomics lab at Institut Pasteur in Paris, France, is filled up with cardboard boxes that look as if they were shipped from an office supply store. Yet, instead of pencils and Post-it notes, the boxes are filled with ancient human remains from South America — several-thousand-year-old vertebrae, petrus bones (which protect inner ear structures),...

Bimekizumab Calms Psoriatic Arthritis in Phase 3 'BE' Trials
https://www.medscape.com/viewarticle/975629

Jun 15th, 2022 - COPENHAGEN, Denmark — For patients with active psoriatic arthritis for whom tumor necrosis factor (TNF) inhibitors failed to produce an adequate response, use of the dual interleukin-17 (IL-17) inhibitor bimekizumab (Bimzelx) was associated with significant improvement in joint, skin, and health-related quality-of-life parameters, compared with placebo, reported investigators in the phase 3, do...